Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02189278 · ClinicalTrials.gov registry record · NA

Improving Adherence to Recommended Surveillance in Breast Cancer Survivors

A NA study of Breast Cancer, sponsored by Duke University.

Completed
Registry status
NA
Development phase
100
Enrollment target
1
Study location

NCT02189278 is a NA study of Breast Cancer that has completed, run by Duke University. The registered enrollment target is 100 participants, below the 2,803-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02189278, a NA study of Breast Cancer, has completed, sponsored by Duke University.

COMPLETED
Registry status
NA
Development phase
100 participants
Enrollment target
1
Study location

Study Summary

Evidence-based guidelines recommend cancer surveillance procedures for breast cancer survivors including physical examination, mammography, breast self-exam, and gynecologic follow-up. The early detection of recurrent and new cancers can best be achieved through the combined, on schedule use of these surveillance procedures. Yet, data suggest that up to 55% of breast cancer survivors do not undergo these procedures as recommended. This study tests a telephone-based psychosocial intervention aimed at improving adherence to recommended surveillance in breast cancer survivors. The psychosocial intervention for improving adherence is compared to treatment as usual.

Conditions Studied

Interventions

  • BEHAVIORAL Psychosocial Intervention

Study Locations (1)

North Carolina

  • Duke University - Durham

Trial Details

FieldValue
Enrollment Target 100 participants
Start Date 2013-10
Est. Completion 2017-06-12
Phase NA

Sponsor

Duke University

1,725 total trials

What the Registry Record Tells You About NCT02189278

The ClinicalTrials.gov registry entry for NCT02189278 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,803-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (96% lower). The listed sponsor is Duke University, which has 1,725 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Breast Cancer appearing as the primary indexed condition, and to 1 intervention - of which Psychosocial Intervention is the first listed.

NCT02189278 reports 1 study location spanning 1 distinct geographic area - top geographies include North Carolina.

Frequently Asked Questions

What is clinical trial NCT02189278 about?

NCT02189278 is a clinical study titled "Improving Adherence to Recommended Surveillance in Breast Cancer Survivors". Evidence-based guidelines recommend cancer surveillance procedures for breast cancer survivors including physical examination, mammography, breast self-exam, and gynecologic follow-up. The early detection of recurrent and new cancers can best be achieved through the combined, on schedule use of thes...

What is the current status of trial NCT02189278?

This trial is currently completed. It is a NA study. The enrollment target is 100 participants. The study started on 2013-10. Estimated completion is 2017-06-12.

What conditions does trial NCT02189278 study?

This clinical trial studies the following conditions: Breast Cancer.

What interventions are being tested in trial NCT02189278?

The interventions under investigation include: Psychosocial Intervention (BEHAVIORAL).

Who is sponsoring clinical trial NCT02189278?

This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02189278 being conducted?

This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Breast Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.